{"id":"urapidil-eupressyl","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the 5-HT1A receptor, urapidil reduces the vasoconstrictive effects of serotonin, leading to vasodilation and a decrease in blood pressure. This mechanism is thought to contribute to its antihypertensive effects.","oneSentence":"Urapidil is a selective and competitive antagonist of the 5-HT1A receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:41.060Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT02558023","phase":"PHASE3","title":"The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2015-09","conditions":"Hypertension, Preeclampsia","enrollment":14},{"nctId":"NCT00409253","phase":"PHASE3","title":"Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2007-06","conditions":"Hypertension During Pre-Eclampsia","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"URAPIDIL (EUPRESSYL*)","genericName":"URAPIDIL (EUPRESSYL*)","companyName":"University Hospital, Strasbourg, France","companyId":"university-hospital-strasbourg-france","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Urapidil is a selective and competitive antagonist of the 5-HT1A receptor. Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}